Pharma Asset Strategy

(3 Credits)

Pharmaceutical drug development can take years and billions of dollars to place one drug into the market. At the core of any drug development strategy is expectation of how well the therapy of interest would perform and what financial returns are to be expected. This course is aimed at familiarizing students with understanding pharma asset strategy, including understanding the potential of the indication, the therapy’s differentiation, and projected financial returns. The course will mimic real-world asset strategy development as applied in industry. | Prerequisites: BT-GY 6013